People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Biotechnology, Other Health Care, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Harpoon Medical, Inc. | — | Biotechnology | Seed | $7.8M | $173.2M | 2014 |
| Confluence Life Sciences, Inc. | — | Other Health Care | Series A | $5.7M | $97.5M | 2016 |
| Slate Bio, Inc. | — | Biotech / Pharma | Seed | $4.8M | $29.9M | 2022 |
| Envisionier Medical Technologies, Inc. | — | Other Health Care | Pre-Seed | $390K | $12.0M | 2009 |
Kyparissia Sirinakis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kyparissia Sirinakis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Gallagher | 1 | 11 |
| Charles Bolten | 1 | 10 |
| Dan Broderick | 1 | 7 |
| James Cox | 1 | 6 |
| Mark Collins | 1 | 5 |
| Robert Beardsley | 1 | 5 |
| Walter Smith | 1 | 4 |
| Robert Creeden | 1 | 4 |
| William Niland | 1 | 4 |
| ANDREW J. KROUSE | 1 | 4 |
| Joseph Monahan | 1 | 3 |
| ANDREW KROUSE | 1 | 2 |
| James Gammie | 1 | 2 |
| Peter Boyd | 1 | 2 |
| Michael Hertzberg | 1 | 2 |
| David Guy | 1 | 1 |
| Daniel Janiak | 1 | 1 |
| Jennifer Bohnert | 1 | 1 |
| Thomas Smart | 1 | 1 |
| Kurt Woerpel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.